We are seeking a Head of Manufacturing – Protein Therapeutics to be responsible and oversee all aspects of biologics manufacturing,…
Read More
We are seeking an Executive Director/Vice-President/Head of Translational or Experimental Medicine to be responsible for late preclinical/early clinical development of…
We are seeking an Executive Director/Vice-President/Head of Preclinical and Nonclinical Development to be responsible for nonclinical development of all Alpine’s…
We are seeking a Medical Director to be responsible for the design, execution, analysis, interpretation, and presentation of clinical and…
— Data Presented at 59th American Society of Hematology Annual Meeting & Exposition — SEATTLE, December 9, 2017 – Alpine…
— Data Presented at 2017 San Antonio Breast Cancer Symposium –– SEATTLE, December 6, 2017 – Alpine Immune Sciences, Inc….
New preclinical data to be presented at multiple upcoming scientific meetings Strong balance sheet with $87.2 million in cash, cash…
— Company’s vIgD Platform Well Positioned to Realize Next Generation Immuno-Oncology Therapeutics — SEATTLE, November 10, 2017 – Alpine Immune…
–Poster to be Presented at 2017 ACR/ARHP Annual Meeting– SEATTLE, November 6, 2017 – Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a…
SEATTLE, WA – October, 23, 2017— Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for…